Physician profile
Ronald Cossman
NPI 1932161619
$3,274.69
in general payments reported to CMS, 2019-2025
11 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.93 · 2020: $154 · 2021: $55.83 · 2022: $395 · 2023: $1,230 · 2024: $1,033 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Travel and Lodging: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.43 |
| Travel and Lodging | $813.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,290.21 | 2020-2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $926.27 | 2023-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Konect Resilia |
| Abiomed | $494.52 | 2022-2025 | Impella |
| Medtronic, INC. | $138.46 | 2021-2022 | |
| Abbott Laboratories | $134.53 | 2023 | Navitor |
| Pfizer INC. | $125.00 | 2020 | |
| Getinge USA Sales, LLC | $75.27 | 2023-2024 | Vasoview Hemopro 2 |
| Vapotherm INC | $35.95 | 2019 | |
| Ambu INC. | $23.50 | 2022 | |
| Lilly USA, LLC | $17.85 | 2019 | |
| Intuitive Surgical, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Cossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.